Ferry Ossendorp, PhDProfessor in Synthetic Vaccine Biology at Leiden University Medical Center
Ferry Ossendorp is heading the Tumor Immunology Group in the Leiden University Medical Center, The Netherlands.
He is Professor in Cancer Vaccine Biology and current research is focusing on improving immunotherapy of cancer. Dendritic cells are studied to optimally induce T cell immunity against tumor antigens by effective antigen targeting, processing and MHC presentation. The tumor microenvironment is studied in cellular and molecular detail. Aim is to modulate immune suppression by using specific antibodies and drugs to improve cancer immunotherapy. Synthetic peptides conjugated to Toll like receptor ligands are currently explored in phase I clinical studies in cancer patients.